Sai Parenterals rallied 3.33% to Rs 544.15 after the company announced that its subsidiary, Noumed Pharmaceuticals, has renewed its OTC Medicines Supply Agreement with one of Australia's leading multi-billion-dollar pharmacy chains.
Market Samachar is a news aggregator. This article was originally published by Share Market Today. Tap the button above to read the full story on their site.